Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.3456
Delayed Data
As of Feb 16
 +0.001 / +0.29%
Today’s Change
0.31
Today|||52-Week Range
0.85
-3.60%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.34
Today’s open0.36
Day’s range0.34 - 0.36
Volume121,478
Average volume (3 months)362,555
Market cap$56.1M
Data as of 8:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+111.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+65.82%
P/E ratioNM
Price/Sales4.51
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...-0.00-2.17%
FLKSFlex Pharma Inc+0.02+0.47%
CXRXConcordia Internatio...+0.03+3.70%
PTNPalatin Technologies...+0.01+1.26%
Data as of 8:00pm ET, 02/16/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$22.0M
Annual profit (last year)-$14.3M
Net profit margin-65.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
CFO, COO, Secretary &
Treasurer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts